Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 240 000 | déclaré | 02 janv. 2026 | tx 26+1 326 888−140 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 240 000 | 0.00 USD | deriv |
| 01 juil. 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15 000 | 1.50 USD | |
| 01 juil. 2025 | SALE | ARS Pharmaceuticals, Inc. | 15 000 | 16.99 USD | |
| 01 juil. 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15 000 | 0.00 USD | deriv |
| 18 juin 2025 | SALE | ARS Pharmaceuticals, Inc. | 15 000 | 16.00 USD | |
| 18 juin 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15 000 | 1.50 USD | |
| 18 juin 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15 000 | 0.00 USD | deriv |
| 20 mars 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 1.50 USD | |
| 20 mars 2025 | SALE | ARS Pharmaceuticals, Inc. | 10 000 | 14.00 USD | |
| 20 mars 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 02 janv. 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 152 300 | 0.00 USD | deriv |
| 04 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 6 283 | 14.00 USD | |
| 04 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 6 283 | 1.50 USD | |
| 02 déc. 2024 | SALE | ARS Pharmaceuticals, Inc. | 3 717 | 14.11 USD | |
| 02 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 3 717 | 1.50 USD | |
| 02 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 3 717 | 0.00 USD | deriv |
| 04 déc. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 6 283 | 0.00 USD | deriv |
| 18 sept. 2024 | SALE | ARS Pharmaceuticals, Inc. | 10 000 | 14.00 USD | |
| 18 sept. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 1.50 USD | |
| 18 sept. 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 19 août 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 1.50 USD | |
| 19 août 2024 | SALE | ARS Pharmaceuticals, Inc. | 10 000 | 14.00 USD | |
| 19 août 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 02 janv. 2024 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 200 000 | 0.00 USD | deriv |
| 03 janv. 2023 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 50 000 | 0.00 USD | deriv |